Antimicrobial Resistance and Immunisation

Houses of Parliament | July 2018 |Antimicrobial Resistance and Immunisation

A new POSTnote, based on literature reviews and interviews with range of stakeholders, and externally peer reviewed, has been released from the House of Commons Library. This POSTnote considers the rise of antimicrobial resistance and immunisation. 

AMR
Image source: researchbriefings.parliament.uk

Key points from the POSTNOTE:

  • Antimicrobial resistance (AMR) has reached a point where some infections may become untreatable.
  • Immunisation is one strategy to tackle AMR, by decreasing rates of infection and thereby antibiotic use and preventing the development of resistant infections.
  • The World Health Organization has developed a list of pathogens where AMR is of most concern and new antibiotics are needed; there is no equivalent for vaccines.
  • Quantifying the impact of immunisation on AMR and incorporating this into calculating the cost-effectiveness of vaccines is still an area of ongoing research.
  • Using immunisation to tackle AMR depends on wider use and increased uptake of existing vaccines, and increasing the development of new ones (Source: House of Commons Library).

The briefing Antimicrobial Resistance and Immunisation is available from the House of Commons Library 

Advertisements

Vaccine update: October 2017

This vaccine update provides immunisation practitioners with the latest developments in vaccines, vaccination policies and procedures.

The vaccine update October edition 271 features:

  • influenza vaccination and patients on therapy for HIV infection (highly active anti-retroviral therapy – HAART)
  • survey for GPs about diagnosis and management of blood-borne viruses (BBV) among migrants
  • call for GP or school practice improvement
  • vaccine coverage for pertussis vaccination programme for pregnant women: update to June 2017
  • latest infant Meningitis B and school leaver MenACWY vaccine coverage estimates published
  • latest UK vaccine coverage figures for children aged up to 5 published
  • interpretation of vaccine storage requirements
  • The Vaccination of individuals with uncertain or incomplete vaccination status has been updated
  • flu vaccine information and availability for the children’s national flu vaccination programme 2017 to 2018
  • eligibility of children for flu vaccines
  • giving a second dose of LAIV
  • influenza Vaccines for the 2017 to 2018 influenza season
  • Hexavalent vaccine (Infanrix hexa®)
  • ordering for Infanrix hexa® (DTaP/IPV/Hib/HepB) is open on ImmForm
  • change to InterVax BCG vaccine ordering restrictions
  • to be aware of vaccine pack changes
  • change to Rotarix presentation
  • shortage of pneumococcal polysaccharide 23-valent vaccine (PPV23)
  • vaccine supply for non-routine programmes
  • historical vaccine development and introduction of routine vaccine programmes in the UK

Full update available at Public Health England

Flu immunisation for early years settings including child minders

Guidance for early years childcare settings on the nasal spray flu vaccination for preschool children. | Public Health England

This guidance has been produced for the early years sector to assist staff and childminders and answers the most frequently asked questions regarding the nasal spray flu vaccination being offered to children in this age group.

It is not intended for parents and children as they have their own dedicated leaflet.